Loading clinical trials...
Loading clinical trials...
The purpose of the study is to evaluate the efficacy and safety of two doses of ERB-041 (75 mg and 150 mg) relative to placebo on the relief of endometriosis-related symptoms (dysmenorrhea, pelvic pai...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
NCT07257029 · Provoked Vestibulodynia, Secondary Provoked Vestibulodynia, and more
NCT07472842 · Endometriosis, Pelvic Pain Syndrome, and more
NCT07471373 · Endometriosis, Infertility, and more
NCT05951452 · Endometriosis
NCT06611501 · Pelvic Pain, Endometriosis
Montgomery, Alabama
Chandler, Arizona
Phoenix, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions